December 19, 2022 | Press Release
Boston Cell Standards obtains FDA approval for its IHControls panel
The Latest News from BCS
December 20, 2022
National Study Confirms Effectiveness of New Tools for Standardizing Estrogen Receptor Testing
Continue Reading
December 20, 2022
Landmark Study by Boston Cell Standards Validates First Reference Standards for Immunohistochemistry Testing
Continue Reading
December 19, 2022
FDA grants 510(k) clearance for Boston Cell Standards’ IHControls panel
Continue Reading